These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2888148)

  • 1. The nucleus accumbens and antidepressants: modulation of ergometrine-induced hyperactivity by typical and atypical antidepressants and neuroleptics in rats.
    Cools AR
    Psychopharmacology (Berl); 1987; 92(3):350-7. PubMed ID: 2888148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Typical and atypical antidepressant drug effects on locomotor activity after intra-accumbens injections in the rat.
    Oosterloo SK; Cools AR
    Eur J Pharmacol; 1985 Nov; 118(1-2):45-51. PubMed ID: 4085549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugs.
    Rupniak NM; Hall MD; Kelly E; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
    J Neural Transm; 1985; 62(3-4):249-66. PubMed ID: 2863324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the atypical neuroleptics carbidine and sulpiride on dopamine biosynthesis in the synaptosomes of the nucleus accumbens septi in rats].
    Kudrin VS; Hetey L; Morgenshtern R; Raevskiĭ KS; Olssner W
    Farmakol Toksikol; 1987; 50(2):16-20. PubMed ID: 2884129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin and antidepressant drugs antagonize melatonin-induced behavioural changes after injection into the nucleus accumbens of rats.
    Gaffori O; Van Ree JM
    Neuropharmacology; 1985 Mar; 24(3):237-44. PubMed ID: 2859542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesolimbic dopamine and its control of locomotor activity in rats: differences in pharmacology and light/dark periodicity between the olfactory tubercle and the nucleus accumbens.
    Cools AR
    Psychopharmacology (Berl); 1986; 88(4):451-9. PubMed ID: 3085132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study.
    Moghaddam B; Bunney BS
    J Neurochem; 1990 May; 54(5):1755-60. PubMed ID: 1969939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ergometrine and its biphasic action at dopaminergic receptors in the nucleus accumbens of rats.
    Cools AR
    Pharmacology; 1978; 16 Suppl 1():93-8. PubMed ID: 643907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic potentiation of neuroleptic effects in the nucleus accumbens.
    Vance MA; Blumberg JB
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):345-8. PubMed ID: 6136070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced modulation of locomotor hyperactivity induced by picrotoxin in nucleus accumbens.
    Morgenstern R; Mende T; Gold R; Lemme P; Oelssner W
    Pharmacol Biochem Behav; 1984 Oct; 21(4):501-6. PubMed ID: 6504948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (3,4-Dihydroxyphenylimino)-2-imidazoline (DPI) and its action at noradrenergic and dopaminergic receptors in the nucleus accumbens of rats: mesolimbic catecholamine receptors and hyperactivity.
    Cools AR; Oosterloo SK
    J Neural Transm Suppl; 1983; 18():181-8. PubMed ID: 6308148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
    Weiss F; Ettenberg A; Koob GF
    Psychopharmacology (Berl); 1989; 99(3):409-15. PubMed ID: 2574480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics.
    Halperin R; Guerin JJ; Davis KL
    Psychopharmacology (Berl); 1989; 98(3):386-91. PubMed ID: 2568659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulpiride blocks postsynaptic dopamine receptors in the nucleus accumbens.
    Morgenstern R; Fink H
    J Neural Transm; 1985; 61(3-4):151-60. PubMed ID: 3989521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic antidepressant treatment on noradrenergic modulation of [3H]dopamine release from rat nucleus accumbens and striatal slices.
    Russell VA; Nurse B; Lamm MC; Taljaard JJ
    Brain Res; 1987 Apr; 410(1):78-82. PubMed ID: 3472627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium and bupropion antagonise the phasic changes in locomotor activity caused by dopamine infused into the rat nucleus accumbens.
    Barnes JC; Costall B; Domeney AM; Naylor RJ
    Psychopharmacology (Berl); 1986; 89(3):311-6. PubMed ID: 3088656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term consequences of antagonism by neuroleptics of behavioural events occurring during mesolimbic dopamine infusion.
    Costall B; Domeney AM; Naylor RJ
    Neuropharmacology; 1984 Mar; 23(3):287-94. PubMed ID: 6145111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of oxaprotiline enantiomers given repeatedly on the behavioural effects of d-amphetamine and dopamine injected into the nucleus accumbens.
    Maj J; Wedzony K
    Eur J Pharmacol; 1988 Jan; 145(2):97-103. PubMed ID: 3350045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.